Evidence map›Paper›PMID 22780223›Full record

ArticleAddiction biology2014

NrCAM-regulating neural systems and addiction-related behaviors.

Hiroki Ishiguro, Frank S Hall, Yasue Horiuchi, Takeshi Sakurai, Akitoyo Hishimoto, Martin Grumet, George R Uhl, Emmanuel S Onaivi, Tadao Arinami

Abstract read
In one paragraph

Article in Addiction biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Rbfox1 regulates alternative splicing of Nrcam in primary sensory neurons to mediate peripheral nerve injury-induced neuropathic pain.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Neural cell adhesion molecule NrCAM regulates Semaphorin 3F-induced dendritic spine remodeling.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2014
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 2 countries.

Hiroki IshiguroDepartment of Neuropsychiatry and Clinical Ethics, Graduate School of Medical Science, University of Yamanashi, Chuo, Yamanashi, Japan; Department of Medical Genetics, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Frank S Hall
Yasue Horiuchi
Takeshi Sakurai
Akitoyo Hishimoto
Martin Grumet
George R Uhl
Emmanuel S Onaivi
Tadao Arinami
National Institute on Drug Abuse · USUniversity of Tsukuba · JPIcahn School of Medicine at Mount Sinai · USKobe University · JPRutgers, The State University of New Jersey · USUniversity of Yamanashi · JPWilliam Paterson University · US

Funding

Genetic Approaches To Characterizing Drug Responses And Vulnerabilities: MiceZIADA000165 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI UHL, GEORGE RICHARD · 2009 to 2016
$7.9M
Molecular Genetic Bases for Quit SuccessZIADA000537 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI UHL, GEORGE RICHARD · 2009 to 2015
$2.9M
Understanding addiction vulnerability genesZIADA000492 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI UHL, GEORGE RICHARD · 2009 to 2015
$1.9M
Intramural NIH HHS Z99 DA999999Intramural NIH HHS ZIA DA000165
6 · The paper itself

Abstract

We have previously shown that a haplotype associated with decreased NrCAM expression in brain is protective against addiction vulnerability for polysubstance abuse in humans and that Nrcam knockout mice do not develop conditioned place preferences for morphine, cocaine or amphetamine. In order to gain insight into NrCAM involvement in addiction vulnerability, which may involve specific neural circuits underlying behavioral characteristics relevant to addiction, we evaluated several behavioral phenotypes in Nrcam knockout mice. Consistent with a potential general reduction in motivational function, Nrcam knockout mice demonstrated less curiosity for novel objects and for an unfamiliar conspecific, showed also less anxiety in the zero maze. Nrcam heterozygote knockout mice reduced alcohol preference and buried fewer marbles in home cage. These observations provide further support for a role of NrCAM in substance abuse including alcoholism vulnerability, possibly through its effects on behavioral traits that may affect addiction vulnerability, including novelty seeking, obsessive compulsion and responses to aversive or anxiety-provoking stimuli. Additionally, in order to prove glutamate homeostasis hypothesis of addiction, we analyzed glutamatergic molecules regulated by NRCAM expression. Glutaminase appears to be involved in NrCAM-related molecular pathway in two different tissues from human and mouse. An inhibitor of the enzyme, prolyl-leucyl-glycinamide, treatment produced, at least, some of the phenotypes of mice shown in alcohol preference and in anxiety-like behavior. Thus, NrCAM could affect addiction-related behaviors via at least partially modulation of some glutamatergic pathways and neural function in brain.

Indexed as

Adaptation, PsychologicalAlcohol DrinkingAnalgesics, OpioidAnimalsAnxietyBehavior, AddictiveCell Adhesion MoleculesCentral Nervous System DepressantsConditioning, PsychologicalEthanolExploratory BehaviorMaleMaze LearningMice, Inbred C57BLMice, KnockoutMorphineAnalgesics, OpioidCell Adhesion MoleculesCentral Nervous System DepressantsEthanolMorphineMSH Release-Inhibiting HormoneNrcam protein, mouseBehaviorcell adhesion moleculeglutamate

Identifiers

PMID22780223
PMCPMC3470748
OpenAlexW1561518847

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.